140 results on '"Komiya, Kazutoshi"'
Search Results
2. Phase I study of amrubicin plus cisplatin and concurrent accelerated hyperfractionated thoracic radiotherapy for limited‐disease small cell lung cancer: protocol of ACIST study
3. O1-2-4 - Clarification of mechanisms of acquired resistance for afatinib using plasma samples
4. Mina53, a novel c-Myc target gene, is frequently expressed in lung cancers and exerts oncogenic property in NIH/3T3 cells
5. Diffuse bone marrow uptake of fluorodeoxyglucose in a patient with aleukaemic acute lymphoblastic leukaemia
6. Establishment of a new method, transcription–reverse transcription concerted reaction, for detection of plasma hnRNP B1 mRNA, a biomarker of lung cancer
7. Mutation profile of EGFR gene detected by denaturing high-performance liquid chromatography in Japanese lung cancer patients
8. Application of a Highly Sensitive Detection System for Epidermal Growth Factor Receptor Mutations in Plasma DNA
9. A Noninvasive System for Monitoring Resistance to Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors with Plasma DNA
10. Association of Genetic Polymorphisms With Afatinib-induced Diarrhoea
11. Exon 19 of EGFR mutation in relation to the CA-repeat polymorphism in intron 1
12. Sjögren Syndrome Complicated with Cystic Lung Disease and Pulmonary Amyloidosis
13. Updated Survival Data for a Phase I/II Study of Carboplatin plus Nab‐Paclitaxel and Concurrent Radiotherapy in Patients with Locally Advanced Non‐Small Cell Lung Cancer
14. Nab-paclitaxel plus ramucirumab combination therapy as second-line with advanced gastric cancer:Retrospective study
15. Discontinuation due to immune‐related adverse events is a possible predictive factor for immune checkpoint inhibitors in patients with non‐small cell lung cancer
16. Paraneoplastic Limbic Encephalitis Complicated with Small Cell Lung Cancer at the Time of Recurrence
17. Updated survival date of phase I/II study of carboplatin plus nab-paclitaxel and concurrent radiotherapy for patients with locally advanced non-small cell lung cancer.
18. Primary Pulmonary Colloid Adenocarcinoma: How Can We Obtain a Precise Diagnosis?
19. Mechanisms of acquired resistance to afatinib clarified with liquid biopsy
20. A case of osimertinib-resistant lung adenocarcinoma responded effectively to alternating therapy
21. Successful treatment of pulmonary nocardiosis with fluoroquinolone in bronchial asthma and bronchiectasis
22. Phase I/II study of carboplatin plus nab-paclitaxel and concurrent radiotherapy for patients with locally advanced non–small cell lung cancer
23. Investigation of appropriate pre-analytical procedure for circulating free DNA from liquid biopsy
24. Abstract 3646: Investigation of origin of circulating free DNA: Is exosomal DNA the carrier
25. Signet Ring Cell Carcinoma of Unknown Primary Complicated with Pulmonary Tumor Thrombotic Microangiopathy and Krukenberg Tumor
26. Current Status and Problems of T790M Detection, a Molecular Biomarker of Acquired Resistance to EGFR Tyrosine Kinase Inhibitors, with Liquid Biopsy and Re-biopsy
27. Automated DNA extraction using cellulose magnetic beads can improve EGFR point mutation detection with liquid biopsy by efficiently recovering short and long DNA fragments
28. Severity and predictive factors of adverse events in pemetrexed-containing chemotherapy for non-small cell lung cancer
29. Clarification of mechanisms of acquired resistance for afatinib using plasma samples
30. Abstract 2751: Automatic DNA extraction system can improve theEGFRpoint mutation detection rate of liquid biopsy
31. Plasma T790M and HGF as potential predictive markers for EGFR-TKI re-challenge
32. Characteristics and prognosis of microscopic polyangiitis with bronchiectasis
33. P3.02a-027 A Retrospective Analysis of the Efficacy and Safety of ALK Inhibitors in ALK-Positive Lung Cancer Patients
34. P2.03a-056 Phase II Trial of Weekly Nab-Paclitaxel for Previously Treated Advanced Non–Small Cell Lung Cancer: KTOSG Trial 1301
35. SPARC is a possible predictive marker for albumin-bound paclitaxel in non-small-cell lung cancer
36. P3-029 - Nab-paclitaxel plus ramucirumab combination therapy as second-line with advanced gastric cancer:Retrospective study
37. Erratum to “Expression of Mina53, a novel c-Myc target gene, is a favorable prognostic marker in early stage lung cancer” [Lung Cancer 69/2 (2010) 232–238]
38. Clarification of mechanisms of acquired resistance for EGFR-TKIs using plasma samples
39. SPARC is a possible predictive marker for albumin-bound paclitaxel in non-small-cell lung cancer
40. Phase II trial of weekly nab-paclitaxel for previously treated advanced non–small cell lung cancer: Kumamoto thoracic oncology study group (KTOSG) trial 1301
41. Coexistence of lung cancer and immunoglobulin G4-related lung disease in a nodule: a case report
42. A case with cancer of unknown primary diagnosed pathologically retroperitoneal squamous cell carcinoma
43. Abstract 1504: Usefulness of peripheral blood for monitoring of acquired resistance to EGFR tyrosine kinase inhibitors in NSCLC
44. O3-8-1 - Clarification of mechanisms of acquired resistance for EGFR-TKIs using plasma samples
45. Severe eosinophilic pneumonia presenting during gemcitabine adjuvant chemotherapy
46. Markers that can Reflect Asthmatic Activity before and after Reduction of Inhaled Corticosteroids: A Pilot Study
47. Coexistence of lung cancer and immunoglobulin G4-related lung disease in a nodule: a case report.
48. Abstract 2089: Fully automated SNP detection from whole blood and mutation detection from plasma-free DNA
49. 子宮筋腫術後10年目に胸部異常陰影で発見された良性転移性平滑筋腫の1例
50. Abstract 4117: A non-invasive system for monitoring resistance to EGFR tyrosine kinase inhibitors with plasma DNA in lung cancer patients
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.